SEARCH

SEARCH BY CITATION

References

  • Aggarwal, S. & Pittenger, M.F. (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 18151822.
  • Anderson, B.E., McNiff, J.M., Matte, C., Athanasiadis, I., Shlomchik, W.D. & Shlomchik, M.J. (2004) Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood, 104, 15651573.
  • Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. (1996) Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. Journal of Experimental Medicine, 184, 387396.
  • Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R.M., Locatelli, F. & Fibbe, W.E. (2007) Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 110, 27642767.
  • Bartholomew, A., Patil, S., Mackay, A., Nelson, M., Buyaner, D., Hardy, W., Mosca, J., Sturgeon, C., Siatskas, M., Mahmud, N., Ferrer, K., Deans, R., Moseley, A., Hoffman, R. & Devine, S.M. (2001) Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo. Human Gene Therapy, 12, 15271541.
  • Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E. & Rachmilewitz, J. (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, 22142219.
  • Bieback, K. & Kluter, H. (2007) Mesenchymal stromal cells from umbilical cord blood. Current Stem Cell Research & Therapy, 2, 310323.
  • Bieback, K., Kern, S., Kluter, H. & Eichler, H. (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells, 22, 625634.
  • Burt, R.K., Loh, Y., Pearce, W., Beohar, N., Barr, W.G., Craig, R., Wen, Y., Rapp, J.A. & Kessler, J. (2008) Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. Journal of the American Medical Association, 299, 925936.
  • Calvi, L.M., Adams, G.B., Weibrecht, K.W., Weber, J.M., Olson, D.P., Knight, M.C., Martin, R.P., Schipani, E., Divieti, P., Bringhurst, F.R., Milner, L.A., Kronenberg, H.M. & Scadden, D.T. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425, 841846.
  • Caplan, A.I. (2009) Why are MSCs therapeutic? New data: new insight. The Journal of Pathology, 217, 318324.
  • Cetrulo, Jr, C.L. (2006) Cord-blood mesenchymal stem cells and tissue engineering. Stem Cell Reviews, 2, 163168.
  • Cohen, J.L., Trenado, A., Vasey, D., Klatzmann, D. & Salomon, B.L. (2002) CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. Journal of Experimental Medicine, 196, 401406.
  • Davies, J.D., O’Connor, E., Hall, D., Krahl, T., Trotter, J. & Sarvetnick, N. (1999) CD4+ CD45RB low-density cells from untreated mice prevent acute allograft rejection. Journal of Immunology, 163, 53535357.
  • Deans, R.J. & Moseley, A.B. (2000) Mesenchymal stem cells: biology and potential clinical uses. Experimental Hematology, 28, 875884.
  • Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noel, D. & Jorgensen, C. (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 102, 38373844.
  • Egermann, M., Baltzer, A.W., Adamaszek, S., Evans, C., Robbins, P., Schneider, E. & Lill, C.A. (2006) Direct adenoviral transfer of bone morphogenetic protein-2 cDNA enhances fracture healing in osteoporotic sheep. Human Gene Therapy, 17, 507517.
  • Erices, A., Conget, P. & Minguell, J.J. (2000) Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology, 109, 235242.
  • Feldmann, Jr, R.E., Bieback, K., Maurer, M.H., Kalenka, A., Burgers, H.F., Gross, B., Hunzinger, C., Kluter, H., Kuschinsky, W. & Eichler, H. (2005) Stem cell proteomes: a profile of human mesenchymal stem cells derived from umbilical cord blood. Electrophoresis, 26, 27492758.
  • Flynn, A., Barry, F. & O’Brien, T. (2007) UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy, 9, 717726.
  • Friedenstein, A.J., Chailakhjan, R.K. & Lalykina, K.S. (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell & Tissue Kinetics, 3, 393403.
  • Gnecchi, M., He, H., Liang, O.D., Melo, L.G., Morello, F., Mu, H., Noiseux, N., Zhang, L., Pratt, R.E., Ingwall, J.S. & Dzau, V.J. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nature Medicine, 11, 367368.
  • Godfrey, W.R., Ge, Y.G., Spoden, D.J., Levine, B.L., June, C.H., Blazar, B.R. & Porter, S.B. (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood, 104, 453461.
  • Godfrey, W.R., Spoden, D.J., Ge, Y.G., Baker, S.R., Liu, B., Levine, B.L., June, C.H., Blazar, B.R. & Porter, S.B. (2005) Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood, 105, 750758.
  • Hanash, A.M. & Levy, R.B. (2005) Donor CD4+CD25+ T cells promote engraftment and tolerance following MHC-mismatched hematopoietic cell transplantation. Blood, 105, 18281836.
  • Hara, M., Kingsley, C.I., Niimi, M., Read, S., Turvey, S.E., Bushell, A.R., Morris, P.J., Powrie, F. & Wood, K.J. (2001) IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. Journal of Immunology, 166, 37893796.
  • Hippen, K.L., Harker-Murray, P., Porter, S.B., Merkel, S.C., Londer, A., Taylor, D.K., Bina, M., Panoskaltsis-Mortari, A., Rubinstein, P., Van Rooijen, N., Golovina, T.N., Suhoski, M.M., Miller, J.S., Wagner, J.E., June, C.H., Riley, J.L. & Blazar, B.R. (2008) Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells. Blood, 112, 28472857.
  • Hoffmann, P., Ermann, J., Edinger, M., Fathman, C.G. & Strober, S. (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. Journal of Experimental Medicine, 196, 389399.
  • Joffre, O., Gorsse, N., Romagnoli, P., Hudrisier, D. & Van Meerwijk, J.P. (2004) Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes. Blood, 103, 42164221.
  • Kern, S., Eichler, H., Stoeve, J., Kluter, H. & Bieback, K. (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 12941301.
  • Koc, O.N., Gerson, S.L., Cooper, B.W., Dyhouse, S.M., Haynesworth, S.E., Caplan, A.I. & Lazarus, H.M. (2000) Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. Journal of Clinical Oncology, 18, 307316.
  • Kogler, G., Sensken, S., Airey, J.A., Trapp, T., Muschen, M., Feldhahn, N., Liedtke, S., Sorg, R.V., Fischer, J., Rosenbaum, C., Greschat, S., Knipper, A., Bender, J., Degistirici, O., Gao, J., Caplan, A.I., Colletti, E.J., Almeida-Porada, G., Muller, H.W., Zanjani, E. & Wernet, P. (2004) A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. Journal of Experimental Medicine, 200, 123135.
  • Kogler, G., Sensken, S. & Wernet, P. (2006) Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Experimental Hematology, 34, 15891595.
  • Kucia, M., Reca, R., Campbell, F.R., Zuba-Surma, E., Majka, M., Ratajczak, J. & Ratajczak, M.Z. (2006) A population of very small embryonic-like (VSEL) CXCR4(+)SSEA-1(+)Oct-4+ stem cells identified in adult bone marrow. Leukemia, 20, 857869.
  • Kucia, M., Halasa, M., Wysoczynski, M., Baskiewicz-Masiuk, M., Moldenhawer, S., Zuba-Surma, E., Czajka, R., Wojakowski, W., Machalinski, B. & Ratajczak, M.Z. (2007) Morphological and molecular characterization of novel population of CXCR4+ SSEA-4+ Oct-4+ very small embryonic-like cells purified from human cord blood: preliminary report. Leukemia, 21, 297303.
  • Kunter, U., Rong, S., Djuric, Z., Boor, P., Muller-Newen, G., Yu, D. & Floege, J. (2006) Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. Journal of the American Society of Nephrology, 17, 22022212.
  • Le Blanc, K., Rasmusson, I., Sundberg, B., Gotherstrom, C., Hassan, M., Uzunel, M. & Ringden, O. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363, 14391441.
  • Le Blanc, K., Samuelsson, H., Gustafsson, B., Remberger, M., Sundberg, B., Arvidson, J., Ljungman, P., Lonnies, H., Nava, S. & Ringden, O. (2007) Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia, 21, 17331738.
  • Liu, C.H. & Hwang, S.M. (2005) Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine, 32, 270279.
  • McGuckin, C.P., Forraz, N., Baradez, M.O., Navran, S., Zhao, J., Urban, R., Tilton, R. & Denner, L. (2005) Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Proliferation, 38, 245255.
  • Ning, H., Yang, F., Jiang, M., Hu, L., Feng, K., Zhang, J., Yu, Z., Li, B., Xu, C., Li, Y., Wang, J., Hu, J., Lou, X. & Chen, H. (2008) The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study. Leukemia, 22, 593599.
  • Panepucci, R.A., Siufi, J.L., Silva, Jr, W.A., Proto-Siquiera, R., Neder, L., Orellana, M., Rocha, V., Covas, D.T. & Zago, M.A. (2004) Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells, 22, 12631278.
  • Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. & Daley, G.Q. (2008) Disease-specific induced pluripotent stem cells. Cell, 134, 877886.
  • Phinney, D.G. & Prockop, D.J. (2007) Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells, 25, 28962902.
  • Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S. & Marshak, D.R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143147.
  • Prockop, D.J. (2007) “Stemness” does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clinical Pharmacology and Therapeutics, 82, 241243.
  • Prockop, D.J. (2009) Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Molecular Therapy, 17, 939946.
  • Prockop, D.J. & Olson, S.D. (2007) Clinical trials with adult stem/progenitor cells for tissue repair: let’s not overlook some essential precautions. Blood, 109, 31473151.
  • Rasmusson, I., Ringden, O., Sundberg, B. & Le Blanc, K. (2005) Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Experimental Cell Research, 305, 3341.
  • Reese, J.S., Koc, O.N. & Gerson, S.L. (1999) Human mesenchymal stem cells provide stromal support for efficient CD34+ transduction. Journal of Hematotherapy & Stem Cell Research, 8, 515523.
  • Ringden, O., Uzunel, M., Rasmusson, I., Remberger, M., Sundberg, B., Lonnies, H., Marschall, H.U., Dlugosz, A., Szakos, A., Hassan, Z., Omazic, B., Aschan, J., Barkholt, L. & Le Blanc, K. (2006) Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation, 81, 13901397.
  • Robinson, S.N., Ng, J., Niu, T., Yang, H., McMannis, J.D., Karandish, S., Kaur, I., Fu, P., Del Angel, M., Messinger, R., Flagge, F., De Lima, M., Decker, W., Xing, D., Champlin, R. & Shpall, E.J. (2006) Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells. Bone Marrow Transplantation, 37, 359366.
  • Rubio, D., Garcia-Castro, J., Martin, M.C., De La Fuente, R., Cigudosa, J.C., Lloyd, A.C. & Bernad, A. (2005) Spontaneous human adult stem cell transformation. Cancer Research, 65, 30353039.
  • Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology, 155, 11511164.
  • Sanchez-Fueyo, A., Weber, M., Domenig, C., Strom, T.B. & Zheng, X.X. (2002) Tracking the immunoregulatory mechanisms active during allograft tolerance. Journal of Immunology, 168, 22742281.
  • Da Silva Meirelles, L., Caplan, A.I. & Nardi, N.B. (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells, 26, 22872299.
  • Suri-Payer, E., Amar, A.Z., Thornton, A.M. & Shevach, E.M. (1998) CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. Journal of Immunology, 160, 12121218.
  • Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J. & Sakaguchi, S. (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. International Immunology, 10, 19691980.
  • Taylor, P.A., Lees, C.J. & Blazar, B.R. (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood, 99, 34933499.
  • Taylor, P.A., Panoskaltsis-Mortari, A., Swedin, J.M., Lucas, P.J., Gress, R.E., Levine, B.L., June, C.H., Serody, J.S. & Blazar, B.R. (2004) L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection. Blood, 104, 38043812.
  • Thornton, A.M. & Shevach, E.M. (1998) CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. Journal of Experimental Medicine, 188, 287296.
  • Tolar, J., Nauta, A.J., Osborn, M.J., Panoskaltsis Mortari, A., McElmurry, R.T., Bell, S., Xia, L., Zhou, N., Riddle, M., Schroeder, T.M., Westendorf, J.J., McIvor, R.S., Hogendoorn, P.C., Szuhai, K., Oseth, L., Hirsch, B., Yant, S.R., Kay, M.A., Peister, A., Prockop, D.J., Fibbe, W.E. & Blazar, B.R. (2007) Sarcoma derived from cultured mesenchymal stem cells. Stem Cells, 25, 371379.
  • Tolar, J., Ishida-Yamamoto, A., Riddle, M., McElmurry, R.T., Osborn, M., Xia, L., Lund, T., Slattery, C., Uitto, J., Christiano, A.M., Wagner, J.E. & Blazar, B.R. (2009) Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood, 113, 11671174.
  • Tondreau, T., Meuleman, N., Delforge, A., Dejeneffe, M., Leroy, R., Massy, M., Mortier, C., Bron, D. & Lagneaux, L. (2005) Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells, 23, 11051112.
  • Trenado, A., Charlotte, F., Fisson, S., Yagello, M., Klatzmann, D., Salomon, B.L. & Cohen, J.L. (2003) Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. Journal of Clinical Investigation, 112, 16881696.
  • Wang, J.F., Wang, L.J., Wu, Y.F., Xiang, Y., Xie, C.G., Jia, B.B., Harrington, J. & McNiece, I.K. (2004) Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation. Haematologica, 89, 837844.
  • Weiss, M.L. & Troyer, D.L. (2006) Stem cells in the umbilical cord. Stem Cell Reviews, 2, 155162.
  • Wexler, S.A., Donaldson, C., Denning-Kendall, P., Rice, C., Bradley, B. & Hows, J.M. (2003) Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord and mobilized adult blood are not. British Journal of Haematology, 121, 368374.
  • Wood, K.J. & Sakaguchi, S. (2003) Regulatory T cells in transplantation tolerance. Nature Reviews. Immunology, 3, 199210.
  • Zhao, D., Zhang, C., Yi, T., Lin, C.L., Todorov, I., Kandeel, F., Forman, S. & Zeng, D. (2008) In vivo-activated CD103+CD4+ regulatory T cells ameliorate ongoing chronic graft-versus-host disease. Blood, 112, 21292138.
  • Zuk, P.A., Zhu, M., Ashjian, P., De Ugarte, D.A., Huang, J.I., Mizuno, H., Alfonso, Z.C., Fraser, J.K., Benhaim, P. & Hedrick, M.H. (2002) Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13, 42794295.